THE OPPORTUNITY Are you an AI-native engineer who wants to own the full build–measure–learn loop for a product at the frontier of AI discovery? The Adobe Brand Visibility team builds the systems that determine how enterprise
THE OPPORTUNITY Adobe is looking for a leader to analyze, structure, and continuously improve our Product-Led Growth (PLG) workstreams — aligning them with Adobes operating model while protecting the speed, autonomy, and data-driven decision culture that
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
The mission of Speechify is to make sure that reading is never a barrier to learning. Over 50 million people use Speechify’s text-to-speech products to turn whatever they’re reading – PDFs, books, Google Docs, news articles,
Idorsia Ltd is reaching out for more – We have more ideas, we see more opportunities and we want to help more patients. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical
Senior Software Engineer, Windows/Desktop Applications - Basel, Switzerland Mission The mission of Speechify is to make sure that reading is never a barrier to learning. Over 50 million people use Speechify’s text-to-speech products to turn whatever
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Computational Chemistry / CADD (Level: Principal Scientist to Director)Full-timeAbout usRidgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe. In recent years,
Have you always dreamed of the exciting world of event management combined with marketing? If so, you’ve come to the right place. We are proud to be one of the world’s leading organisers of medical congresses
Location: Basel, Switzerland Contract Duration: 3 years, with possible extension Experience Required: 3+ years. Industry Experience: Utilities & Energy (Energie & Wasserversorgung) or Telecommunications or Banking & Financial Services or Information Technology & Services Role Overview
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Summary Location: Basel, Switzerland or East Hanover, United States (see separate posting) Relocation Support: This role is based in Basel, Switzerland. Novartis is unable to offer relocation support: please only apply if accessible. Imagine shaping how